
Chinese Mainland Approves 1st Domestically Developed 9-Valent HPV Vaccine
The Chinese mainland’s drug regulator approves its first domestically developed 9-valent HPV vaccine, marking the second globally and a breakthrough in public health.
Stay informed, stay connected—news for amigos everywhere.
The Chinese mainland’s drug regulator approves its first domestically developed 9-valent HPV vaccine, marking the second globally and a breakthrough in public health.
China’s new nine-valent HPV vaccine Cecolin 9 offers high protection with fewer doses—a game-changer in cervical cancer prevention.